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RESEARCH ARTICLE

Open Access

The UAE healthy future study: a pilot for a
prospective cohort study of 20,000 United
Arab Emirates nationals
Abdishakur Abdulle1, Abdullah Alnaeemi2, Abdullah Aljunaibi2, Abdulrahman Al Ali2, Khaled Al Saedi2,
Eiman Al Zaabi3, Naima Oumeziane3, Marina Al Bastaki3, Mohammed Al-Houqani4, Fatma Al Maskari4,
Ayesha Al Dhaheri4, Syed M. Shah4, Tom Loney4, Mohamed El-Sadig4, Abderrahim Oulhaj4, Leila Abdel Wareth5,
Wael Al Mahmeed5, Habiba Alsafar6, Benjamin Hirsch6, Fatme Al Anouti7, Jamila Yaaqoub8, Claire K. Inman1,
Aisha Al Hamiz1, Ayesha Al Hosani1, Muna Haji1, Teeb Alsharid1, Thekra Al Zaabi1, Fatima Al Maisary1,
Divya Galani1, Tim Sprosen9, Omar El Shahawy10, Jiyoung Ahn10, Tomas Kirchhoff10, Ravichandran Ramasamy10,
Ann Marie Schmidt10, Richard Hayes10, Scott Sherman10 and Raghib Ali1*

Abstract
Background: The United Arab Emirates (UAE) is faced with a rapidly increasing burden of non-communicable
diseases including obesity, diabetes, and cardiovascular disease. The UAE Healthy Future study is a prospective
cohort designed to identify associations between risk factors and these diseases amongst Emiratis. The study will
enroll 20,000 UAE nationals aged ≥18 years. Environmental and genetic risk factors will be characterized and
participants will be followed for future disease events. As this was the first time a prospective cohort study was
being planned in the UAE, a pilot study was conducted in 2015 with the primary aim of establishing the feasibility
of conducting the study. Other objectives were to evaluate the implementation of the main study protocols, and to
build adequate capacity to conduct advanced clinical laboratory analyses.
Methods: Seven hundred sixty nine UAE nationals aged ≥18 years were invited to participate voluntarily in the
pilot study. Participants signed an informed consent, completed a detailed questionnaire, provided random blood,
urine, and mouthwash samples and were assessed for a series of clinical measures. All specimens were transported
to the New York University Abu Dhabi laboratories where samples were processed and analyzed for routine
chemistry and hematology. Plasma, serum, and a small whole blood sample for DNA extraction were aliquoted and
stored at −80 °C for future analyses.
Results: Overall, 517 Emirati men and women agreed to participate (68% response rate). Of the total participants,
495 (95.0%), 430 (82.2%), and 492 (94.4%), completed the questionnaire, physical measurements, and provided
biological samples, respectively.
Conclusions: The pilot study demonstrated the feasibility of recruitment and completion of the study protocols for
the first large-scale cohort study designed to identify emerging risk factors for the major non-communicable
diseases in the region.
Keywords: Adult, Chronic disease, Cohort studies, Pilot projects, Prospective studies, Public health, United Arab
Emirates
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Background
The United Arab Emirates (UAE), a high-income developing country, has undergone a rapid epidemiological
transition from a traditional semi-nomadic society to a
modern affluent society with a lifestyle characterized by
over-consumption of energy-dense foods and low physical activity [1–3]. As a result, the UAE is facing an increasing burden of non-communicable diseases (NCD)
including obesity, diabetes, and cardiovascular disease
(CVD).
More than a quarter (29%) of all deaths in the UAE
are attributable to cardiovascular disease (CVD) [4], with
a high prevalence of cardiometabolic risk factors [5].
Recent population-wide data showed that over 65% of
adults are either overweight or obese, with 57% having
central obesity [6]. Compared to the United States, one
of the countries with the highest obesity burden, the rate
of pre-diabetes or diabetes in the UAE, is far higher at
44% [1], according to the criteria from the American
Diabetes Association (ADA).
This increasing burden of non-communicable diseases
(NCDs) is largely attributable to complex co-determinants
and risk factors including individual health habits
(e.g., smoking, diet, and physical activity) [7], environmental factors [8], genetic susceptibility [9], human
microbial milieu (microbiome) [10], and socioeconomic conditions [11].
For example, one-quarter of men were reported to
regularly smoke; mostly cigarettes and to a lesser extent
Midwakh and water pipe (hookah/shisha) [12]. The use
of tobacco is also increasing rapidly among adolescents
[13]. In addition, poor nutritional intake and physical
inactivity are common, particularly among females [2].
The consumption of protective dietary factors (e.g.
fruits, vegetables, nuts, whole grains) is suboptimal,
whereas consumption of harmful foods (e.g. processed
meat, red meet, and trans fatty acids) are above recommended levels [5]. Despite the lack of population-wide
studies using objective measures of free-living physical
activity, low levels of physical activity, mostly due to
cultural and climate restrictions, have been self-reported
in adolescent females [14].
To date, no large prospective cohort studies have been
carried out in the UAE, hence, the relative importance
of both established and novel risk factors for NCDs is
largely unexamined (A small sample of Emiratis was recruited into the PURE study [15]). Therefore, the UAE
Healthy Future study (AEHFS), a prospective longitudinal cohort, is designed to recruit 20,000 healthy UAE
nationals. For the sample size calculation, we focus on
risk factors for Diabetes. The 20,000 figure is the minimum number that will enable us to quantify associations
between exposures such as physical activity, BMI, Vitamin
D levels and incident diabetes. As this is a prospective
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cohort study whose primary objective is to understand the
association between risk factors and outcomes, a fully representative sample is not required. Thus we are recruiting
a convenience sample - this is the same approach taken by
many similar cohort studies including, for example, the
UK biobank & Qatar biobank studies [17, 25].
Essentially, we conducted a pilot study to establish
both the study feasibility and to ensure that all protocols
and participant materials were appropriate for the local
population.
The pilot study had five main objectives: 1) develop
participant materials including the information leaflet,
consent form, and questionnaires; 2) assess participation
rates for various recruitment strategies; 3) evaluate the
baseline assessment visit; 4) assess procedures for biological sample collection, transport and processing; and
5) assess participant acceptability of the individual study
components. Here, we present our experience of
conducting the pilot study and the results in relation to
these five objectives.
Subjects and methods
Subjects

The AEHFS is designed to collect detailed self-reported
data in a questionnaire, take physical measurements,
and collect biological specimens - blood, urine, and
mouthwash samples from 20,000 UAE nationals aged
≥18 years. To test the feasibility of the study, we recruited 500 subjects. None of the participants received
any incentives.

Methods
Development of participant materials

The first stage of the pilot study (September to
December 2014) was a series of focus group discussions
with potential participants to develop and optimize the
participants’ information material and study protocols,
the results of which has been published elsewhere [16].
After completion of the focus group discussions, we
revised materials and carried out the actual pilot study
as described here.
Assessment of participation rates for various recruitment
strategies

Making use of modifications suggested from the focus
groups, the second stage of the pilot (actual recruitment
of 500 participants into the cohort study) was carried
out from January to April 2015 at two sites: Zayed
Military Primary Health Care Clinic (ZMH PHCC) and
the Abu Dhabi Blood Bank (ADBB), both of which are
licensed for clinical research by the Health Authority of
Abu Dhabi (HAAD). In each location, individuals who
visited the clinic either for bi-annual medical screening
(at the ZMH PHCC) or to donate blood (at ADBB) were
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invited to participate in the study. About 100 UAE
nationals visit the ZMH PHCC daily whereas the ADBB
receives about 20 UAE nationals daily on average.
All potential participants were given participant information leaflets in either Arabic or English to read and
had the opportunity to ask questions prior to completion
of the recruitment process. The age and gender of nonrespondents, and their reasons for not participating was
also recorded.
Evaluation of baseline assessment visit

All participants were asked to complete a selfadministered questionnaire on a touch screen tablet
computer. Many of the questions were similar to the UK
Biobank Study, a prospective cohort study of 500,000
adults in the UK [17]. The baseline questionnaire focused
on known and potential risk factors for important public
health outcomes including obesity, diabetes, and CVD
[18]. These included questions on socio-demographic
factors, lifestyle/habits, tobacco use, family history and
early life exposures, general health, and psychological state
(using PHQ-8, the Personal Health Questionnaire
Depression Scale) [19, 20]. In the pilot study, we used the
International Physical Activity Questionnaires (IPAQ) to
measure physical activity.
Questions were selected based on their relevance,
reliability, simplicity, and likelihood to show plausible
associations with NCDs. Culturally or religiously sensitive questions such as questions on alcohol consumption
– which is prohibited for Muslims in the UAE - were
excluded.
The questionnaire was translated from English into
Arabic and back-translated into English to check for
linguistic validity. For the Personal Health Questionnaire
Depression Scale (PHQ-8) and the STOP-BANG
Questionnaire for Obstructive Sleep Apnea we used
previously validated Arabic translations [21]. The time
taken to complete the questionnaire and the response
distributions for each question were examined. In a face-toface interview, administered by a trained nurse, participants
were asked about their medication history, past
operations and other past medical history; and their
fasting status. A summary of the questionnaire
components is shown is Table 1. Dietary assessment
will be conducted in the main study through the use
of an online 24-h recall being developed for the use
in the UAE. The full questionnaire is given in Additional file 1.
Physical and clinical measurements

We measured sitting and standing height using a
stadiometer (Seca, HamburgDeutschland) and neck, hip,
and waist circumferences using a standard tape according to international guidelines [22]. Body mass and bio-
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impedance were measured and body mass index (BMI)
was automatically calculated as body weight (kg)/ height
square (meters) using the Tanita MC 780 (Tanita Inc.,
Tokyo, Japan).
Body weight was categorized based on BMI readings
[underweight (< 18.5 kg/m2), normal range (18.5–
24.9 kg/m2), overweight (25.0–29.9 kg/m2), obese class I
(30.0–34.9 kg/m2), obese class II (35.0–39.9 kg/m2),
obese class III (≥ 40.0 kg/m2)] according to world Health
Organization categories. Pre-diabetes and diabetes were
classified according to HbA1c levels: Normal: HBA1C <
5.7%; Pre-diabetes (5.7–6.4%); Diabetes HBA1c > 6.5%.
Hypertension was classified as normal: SBP (90–
119 mmHg) and DBP (60–79 mmHg), Prehypertension:
SBP (120–139 mmHg) or DBP (80–89 mmHg), Stage 1
hypertension: SBP (140–159 mmHg) or DBP (90–
99 mmHg), Stage 2 hypertension: SBP ≥ 160 or DBP ≥
100 mmHg [23]. Hypercholesterolemia was defined by
total cholesterol levels: desirable <200 mg/dl, borderline
high 200–239 mg/dl, and high <240 mg/dl [24].
Hand-grip strength measurements were taken three
times on participants’ right and left hand using a hydraulic
hand dynamometer (Jamar Plus Digital Hand Dynamometer J00105, Jamar, USA) [22], and the highest reading was
recorded for each hand-grip. Brachial blood pressure
readings were taken twice on the upper left arm with
appropriate cuff size with a two-minute interval between
readings using a semi-automated sphygmomanometer
(Omron M10-IT, Omron corporation, Kyoto, Japan). If
the difference in blood pressure readings was ≥5 mmHg,
then a third reading was obtained. A summary of the
physical measurements components is shown is Table 2.
Assessment of procedures for biological sample
collection, transport, and processing

To ensure that all sample handling and analyses could
be completed at NYUAD, laboratories for clinical chemistry, hematology, and immunology were established
prior to the actual recruitment process.
At the assessment centre, a unique barcode was generated for each individual. Samples, along with participants’ signed consent forms were labelled accordingly.
Participants provided several non-fasting specimens
including blood (8 ml SST tube, and 8 ml Plasma EDTA
tube), mouthwash in10 ml of physiological normal saline
(0.9%), and the urine sample (approximately 10 ml) in a
sterile screw-capped urine container. SST tubes were
centrifuged (3500 rpm, 4 °C, for 15 min), but not separated, within 30 min from the time of collection. All
samples were refrigerated (4 °C - 8 °C) and subsequently
transported to NYUAD laboratories in a temperaturecontrolled cooler with adequate spill control contingency
plans. On arrival, SST samples were aliquoted in 1.5 ml
Eppendorf tubes. A proportion of the fresh serum was
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Table 1 Summary of baseline questionnaire components of the UAE healthy future pilot study
Measurement category

Instrument detail

Self-reported Questionnaires
Sociodemographic

Employment status, Marital status, education, income, car ownership,
and household size including workers.

Family history and early life exposures

Family history of major diseases, birth weight, breastfeeding, parental
smoking, childhood body size, residence at birth

Psychosocial factors

Anxiety, depression, social support

Environmental factors

Current address, current (or last) occupation, housing, means of travel, shift work

Lifestyle

Smoking, physical activity, diet, sleep

Health status

Medical history, medications, disability, reproductive history (women)

Nurse interview questionnaire

Current and previous clinical history of the participants and and use of prescription medications

analyzed for routine chemistry using Beckman DXC 600
(Beckman, USA). Regarding the EDTA tubes, a small
whole blood sample was aliquoted and stored at −80 °C
for future DNA extraction prior to sample separation.
Remaining EDTA sample, was centrifuged (3500 rpm,
4 °C, for 15 min). Plasma ETDA was aliquoted in 1.5 ml
Eppendorf tubes and stored at −80 °C. A complete list of
the biochemical markers being analyzed is summarized
in Table 3.
Assessment of acceptability of various parts of the study

A brief post-visit questionnaire was sent to all participants by email or Short Message Service (SMS) to assess
the acceptability of, and seek feedback on, the different
components of the study.
Analyses of data collected in the pilot study

Simple descriptive analyses of selected questions, physical measurements, and biomarkers collected in the pilot
study were carried out to help inform the study protocol
for the main study.

Results
Overall, 517 participants were recruited over four months
from January to April 2015. The response rate was 68%
(517/769) and was similar in both recruitment sites. The
primary reasons given for not taking part in the study
were lack of time (60%), lack of interest (20%), not

convinced e.g. benefits of study (10%), or no particular
reasons (10%). There was no significant difference
between the respondents and non-respondents in terms
of age, gender, or occupation.
Table 4 shows the breakdown of the time taken to
complete the different parts of the assessment visit. On
average, the visit took between 40 to 60 min. Of the 517
participants, 495 (95%) filled out the questionnaire
(although only 80% completed all sections), 430 (82%) had
their physical measurements taken, and 492 (94%)
provided at least one biological specimen -, 462 (89%)
blood samples (plasma and serum), 389 (75%) urine sample, and 409 (79%) mouthwash sample. Many participants
expressed the view that the questionnaire was too long.
Samples were transported to NYUAD laboratories
within 24 h of the collection with no major adverse
temperature effects. All tests performed at NYUAD
laboratory were validated on site for accuracy, precision, linearity using Clinical Laboratory Standards Institute guidelines (CLSI- EP15A2, EP6A, EP9).
Reference ranges validation were also carried out on
normal subjects using the transference method published by CLSI (CLSI C28-A3). Internal Quality control materials were analysed with every analytical run
to control the analytical precision using two levels,
while external laboratory comparisons with Cleveland
Clinic Abu Dhabi (CCAD) Laboratory were used to
control for bias and inaccuracy. CCAD uses External
Proficiency Quality Control material from the College

Table 2 Summary of Physical Measurements of the UAE Healthy Future pilot study
Measurement category

Instrument detail

Physical Measurements
Anthropometrics

Standing and sitting height (Seca 202, Germany), body mass and bio
impedance analysis (Tanita MC-780 MA body analyzer, Tanita Corporation,
Tokyo, Japan), neck, waist, and hip circumference (Wessex non-stretchable sprung tape).

Hand grip strength

Right and left-hand grip strengths (Jamar hydraulic hand dynamometer, Patterson Medical, IL, USA).

Peripheral blood pressure and heart rate

Blood pressure measured twice (Omron M10-IT, Omron corporation, Kyoto, Japan)
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Table 3 List of routine and advanced biochemical markers
measured
Variable Category

Analyte

Bone markers

Calcium
Phosphorus
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Table 4 Time spent in the different recruitment stations
Visit Station

Assessments

Reception &
consent

• Welcome and given a printed copy 5–10
of the Participant Information Leaflet
(Arabic and English)
• Consent taken and form signed

Questionnaire

• Self-administered touch-screen
questionnaire via tablet

Uric acid
Vitamin D
Diabetes

Glucose
Glycated hemoglobin A1c % (HBA1c %) %
Serum receptor for advanced glycation
end-products (RAGE) - endogenous
secretory (es)RAGE and soluble (s)RAGE
Carboxymethil-lysine
Homeostatic model assessment - insulin
resistance (HOMA-IR) test on fasting
participants

Electrolytes and renal
function tests

Chloride

Electrolytes and renal
function tests

Serum creatinine

Urea nitrogen
Full blood count

Full blood count

Inflammation markers

C-Reactive protein
Cholesterol
High density lipoprotein
Low density lipoprotein
Triglycerides
Apolipoprotein A
Apolipoprotein B

Liver function tests

Specimen
Collection

Total (min)

• Collection of blood samples
(about 14 ml)
• Urine sample (50 ml)
• Oral wash (10 ml)

15–25
15

5–10

40–60 min

Potassium
Sodium

Lipid profile

Interview & Physical • Interviewer questionnaire
Measurements
• Blood pressure measurement
• Standing & sitting height
• Body mass
• Waist & hip circumference
• Neck circumference
• Bio-impedance measure
• Hand-grip strength

Time taken
(mins)

Albumin

of American Pathologists (CAP) and is accredited by
CAP.
Of the 517 participants, 495 were included in the final
analysis due to missing data. Age distribution ranged
from 18 to 70 years (67% male) with the majority being
below 40 years old among both males and females. The
mean age ± SD of males (32.6 ± 10.7, n = 332) was significantly higher (P < 0.01) than that of females (30.0 ± 9.9,
n = 159) as shown in Fig. 1.
Table 5 shows selected baseline socio-demographic
characteristics among the participants of the pilot study,
by sex.

Alkaline phosphatase
Alanine transaminase
Aspartate transaminase
Gamma glutamyl transferase
Total bilirubin
Total protein
Minerals

Iron

Urine

Potassium

Magnesium

Sodium
Nitrogen
Micro albumin
Enzymatic Creatinine
Cotinine

Fig. 1 Age distribution of the pilot study participants (n = 495)
among men (32.6 ± 10.6, n = 332) and women (30.1 ± 9.9, n = 159)

Abdulle et al. BMC Public Health (2018) 18:101
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Table 5 Selected baseline socio-demographic characteristics
among the participants of the UAE Heath Future pilot study,
by sex. (N = 491)
Gender
Male
Age Group

Education

Marital status

Female

N

%

< 25

98

29.5 59 37.1

25–34

104 31.3 55 34.6

35–44

81

24.4 29 18.2

45–54

37

11.1 12 7.5

> 55

12

3.6

4

2.5

Illiterate

7

2.2

1

0.7

Primary school

41

13.1 5

3.3

Secondary school

133 42.5 71 46.4

University

105 33.5 68 44.4

Postgraduate

13

4.2

4

2.6

Prefer not to answer

10

3.2

2

1.3

None of the above

4

1.3

2

1.3

Single

107 34.2 81 52.9

Married

196 62.6 57 37.3

Divorced

10

3.2

12 7.8

Widowed

0

0.0

3

Employment status Paid or self-employed

N

%

2.0

163 52.1 62 40.5

Retired

12

3.8

1

0.7

Looking after home or family 41

13.1 23 15.0

Unable sickness or disability

0.0

0

0

0.0

Unemployed

10

3.2

17 11.1

Unpaid or voluntary

3

1.0

0

Student

22

7.0

22 14.4

Prefer not to answer

33

10.5 16 10.5

None of the above

29

9.3

Fig. 2 Body size categories based on body mass index cut-off points
from the World Health Organization, by sex

Table 6 shows the crude (not age-adjusted) prevalence
of self-reported chronic diseases among the participants
stratified by sex.
Figures 2, 3, 4, 5 show the prevalence of overweight
and obesity, pre-diabetes and diabetes, hypertension, and
hypercholesterolemia.

0.0

12 7.8

Table 6 Crude (not age-adjusted) prevalence of self-reported
chronic diseases among the participants of the UAE Health
Future pilot study, by sex
Male
(N = 267)
N
Age (mean ± SD)

33 (11)

Diabetes

20

Female
(N = 140)
%

N

%

30 (10)
8

5

4

Hypertension

28

11

16

11

High Cholesterol

49

18

18

13

Cigarette

51

18

1

1

Midwakh (local pipe)

52

18

1

1

Sheesha (water pipe)

41

14

2

1

Current smoking

Fig. 3 Prevalence of pre-diabetes (HBA1c 5.7 to 6.4%) and diabetes
(>6.5%) according to HbA1c levels, by sex

Abdulle et al. BMC Public Health (2018) 18:101
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Table 7 Responses to selected post recruitment follow-up
questionnaire
Question

Response

Did you read the Participant Information 50% in detail
Leaflet?
40% quick look
10% no
Was the length of the visit?

50% Just right
50% too long

Was the amount of information you
were asked during the visit?

10% too short
40% Just right
50% too long

What were your main reasons for taking To help to improve the
part in the UAEUHFS?
health of future generations.
To have a health check.
Support medical research.
How would you answer if a close friend
or family member were to ask you
“should I participate in the UAEUHFS?”

Fig. 4 Prevalence of pre-hypertension and hypertension among the
participants of the UAE Heath Future pilot study, by sex

Table 7 shows the responses to the follow-up
questionnaire. Of 330 questionnaires sent by email or
SMS, 34 were completed (~10% response rate).
Approximately 50% of the subjects reported that they
fully read and understood the information leaflet. Half
of the respondents thought that the length of the visit
was adequate. However, 50% thought that the

Fig. 5 Prevalence of hypercholesterolemia among the participants
of the UAE Heath Future pilot study, by sex

80% definitely take part
20% not sure

questionnaire time was too long. The majority of participants indicated that helping to improve the health
of future Emirati generations, having a health check,
or supporting medical research as main reasons for
participation. Encouragingly, the overwhelming majority (80%) agreed that they would recommend a family
member or friend to participate in the study.

Discussion
The AEHFS initiative provides for the first time a
unique opportunity to identify causes and specific risk
factors for NCDs among the Emirati population. The
current pilot study was conducted to assess the feasibility of recruiting 20,000 UAE nationals by addressing five specific objectives including developing
participants’ materials, assessing participation rates for
various recruitment strategies, evaluating baseline
visits, assessing procedures for biological sample
handling and analyses of collected data, and assessing
the acceptability of the study.
Our study results show that a high proportion of
UAE nationals (68% response rate) are willing to
participate in research aimed at improving the health
of future generations. This high response rate establishes the feasibility of recruiting 20,000 participants
for the main study. Furthermore, the highest proportion (60%) among subjects who refused to participate
did so due to time constraints only, indicative of the
general acceptability of the study protocols. Considering the time taken to complete the recruitment
process, a research team of one nurse and one
research assistant would be able to recruit about 10
individuals per day. Thus, we think that five recruitment clinics would suffice to recruit the target
number of participants within two years. Based on
the experience from the pilot study, a custom-made
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laboratory information management system (LIMS)
was developed to monitor sample collection, transport, storage, and biochemical analysis.
The participants of our pilot study were relatively
younger than in many other longitudinal studies
internationally, and even within the region [25]. This
young age cohort is useful mainly because of the incidence
of our primary outcome of interest, diabetes, increases
rapidly from the age of 40 years. Further, a younger cohort
will allow us to understand the importance of risk factors
operating from early adulthood. Our current results show
significantly high levels of self-reported diabetes, hypertension, and hypercholesterolemia. As expected and previously reported [26], objective measures of the prevalence
of these diseases were even higher particularly among
males.
The percentage of participants who responded to
our follow-up questionnaire (sent by SMS or email)
was relatively low at 10% and may not be reflective of
the whole sample. Overall, half of the respondents
understood the information leaflet, perhaps as a reflection
of the high literacy rate (90%) among participants. While
patriotism was the single most important promoter to
participation, the length of the questionnaire was an
important obstacle, − thus, the length of the questionnaire
will be reduced to improve completion rates.

Conclusion
The pilot study successfully demonstrated the feasibility
of the study and recruitment for the main study that has
now started and is due to be completed in 2018. As the
first prospective cohort study in Abu Dhabi, the AEHFS
will provide unique and substantive evidence for both
lifestyle and genetic determinants of common diseases
in the Emirati population. The study will be a resource
for researchers throughout the UAE, and the wider
region, with data accessible for all research that will be
of benefit to the local population.
Additional file
Additional file 1: Participant Completed Questionnaire. (DOCX 82 kb)
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